Bioanalytical Method Development

CANTEST Life Sciences group offers the following LC-MS-MS method development and validation services for bioanalytical applications:

• Method Feasibility Assessment
• Method Transfer
• Method Development
• GLP Method Validation
• Cross Validation

Methods can be developed either non-exclusively or exclusively for a sponsor. CANTEST Life Sciences conducts method validations in accordance with the United States Food & Drug Administration (FDA) and the Organisation for Economic Co-operation and Development (OECD), as they apply to bioanalytical methods, and in accordance with procedures described in CANTEST Life Sciences' Standard Operating Procedures (SOPs).

Click here for a complete list of our non-exclusive validated methods.

To view the applicable FDA guidances, click below:
21 CFR Part 58 Good Laboratory Practices: Guidance for Industry Bioanalytical Method Validation

Depending on the complexity, method development project duration can range from one week to a few months. Method validation typically takes about 2 weeks.

For method development and validation, toxicokinetic bioanalysis and clinical bioanalysis, please inquire.